Filing Details

Accession Number:
0001719312-18-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-21 16:08:12
Reporting Period:
2018-06-20
Accepted Time:
2018-06-21 16:08:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1710155 National Vision Holdings Inc. EYE Ophthalmic Goods (3851) 464841717
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1719312 Chris Beasley C/O National Vision Holdings, Inc.,
2435 Commerce Avenue, Bldg. 2200
Duluth GA 30096-4980
Svp, Accounting, & Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-20 6,219 $5.25 6,219 No 4 M Direct
Common Stock Disposition 2018-06-20 6,219 $38.97 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-06-20 6,219 $0.00 6,219 $5.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,604 2025-09-01 No 4 M Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 22, 2018
  2. Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $38.71 to $39.10. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
  3. Of these 48,823 stock options, 12,205 are vested and the remaining 36,618 stock options will vest in three equal annual installments on September 1, 2018, 2019 and 2020. An additional 91,543 stock options which remain subject to liquidity-event performance-based vesting conditions are not included in the table above.